Close
Nordic 9Nordic 9

Amadix (private company)

Spain amadix.com
See something wrong or missing? Let us know
Offices:Valladolid, Madrid
Industry:Health servicesPharma
Business model:B2B

Amadix is a biotechnology company constituted by the partners of TCD Pharma for the development of diagnostic tools in the area of ​​oncology, with several very advanced programs in lung and colon cancer. Its solution, called Colofast, allows to detect if a healthy person will suffer from colon cancer up to fifteen years before showing the first symptoms.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 6.38M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Amadix

Name Criteria
Spain Ability Pharma
50%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Norway Curida
50%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Gradientech
50%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Germany Perfood
50%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Germany Semalytix
50%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France Synapse Medicine
50%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Theolytics
50%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden iCellate
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Spain Oncomatryx
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Italy Harg
47%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top